BRUSSELS FINES SERVIER AND GENERIC ALLIES EURO 427.7 MILLION
July 5th, 2014
FRENCH pharmaco Servier and five generics producers have been fined EUR427.7 million by the European Commission over anti-competitive deals. Brussels says Niche/Unichem, Matrix (now part of Mylan), Teva, Krka and Lupin agreed to protect Servier's bestselling blood pressure medicine, perindopril, from price competition by generics in the European Union (EU). This effectively came out of patent protection in 2003, and the Commission found that a series of generic companies who were preparing to launch generic competitors to this drug, were paid for not doing ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.